- News article -

Customer success-story: Optomed secured 1,97 M€ EU funding for Smartscope-X – affordable, accessible and automatic screening for diabetic retinopathy

12 Oct 2017

In May, the Finnish medical technology company Optomed was granted 1,97 M€ from Horizon 2020 SME Phase 2 instrument under the topic Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well. The funding will help Optomed make their product Smartscope-X the leading solution for diabetic retinopathy screening, supporting the company’s vision to provide affordable eye screenings to everyone.

Diabetic retinopathy is the most frequent cause of preventable blindness in working-aged adults, affecting people with all types of diabetes. Visual impairment and blindness caused by diabetic retinopathy can be prevented through early and effective screening. Currently, screening is costly, time-consuming and needs to be done by an ophthalmologist. Optomed’s solution will allow patients to do the screenings automatically and get the diagnosis in real-time.

Optomed’s fully automated diabetic retinopathy screening solution consists of three main components: a low-cost handheld camera, an automated screening algorithm and a cloud service for eyeground images. As a low-cost and portable solution, Smartscope-X can also provide access to screening for example in developing countries.

Spinverse supported Optomed in project preparation, including help in defining the scope, matching the call and assisting in writing the proposal. After a positive decision from the EU Commission in May 2017, Spinverse supported Optomed in the project negotiation phase.

“The cooperation with Spinverse worked well. The applicant always has the main responsibility during the application process, but the support from Spinverse and their expertise on the application process helped us achieve the desired outcome,” says Seppo Kopsala, CEO of Optomed.

The project officially began in August. Currently, Optomed is working on product development related to the integration between the camera and the software as well as choosing subcontractors for the server solution. Next steps towards the commercialization of Smartscope-X include several clinical tests and commercial pilots in target countries during 2018–2019.

What can you achieve with EU funding? See how we have helped companies create success stories and  contact us to discuss your options.

Photo credit: Optomed

- News -

Relevant posts

innovation CTO Forum EU

Finland’s EU-presidency, bringing impact to EU Innovation Funding?

11 Apr 2019

Finland begins its third EU presidency on 1 July 2019. Leading up to the presidency, both private and public...

ecosystem smart-Memphis Spinverse News

smart-MEMPHIS creates a new value chain for developing self-powering pacemakers and wireless sensors

2 Apr 2019

smart-MEMPHIS, a four-year project joining the forces of nine European companies, universities and research ...

battery ecosystem Spinverse News

Speeding up the development of smart and sustainable battery ecosystems

1 Apr 2019

Finnish and European battery ecosystems were assessed in an extensive study focusing on the current status o...

Spinverse News

Tomas Hedenborg joins Spinverse board as new member

28 Mar 2019

We are delighted to announce Tomas Hedenborg as Spinverse’s newest board member....

White Papers cto ecosystem

Who disrupts the disruptors - The best CTOs are disrupting their jobs

26 Mar 2019

Disruption is one of today’s hottest buzzwords. Disruption and continuous renewal are the norm, and change...

Client News ecosystem Spinverse News

Mirka takes surface finishing business to the digital age with the help of ecosystem

25 Mar 2019

Mirka, renown Nordic high-quality surface finishing products and tools manufacturer, takes a trailblazer rol...